266 related articles for article (PubMed ID: 35986397)
1. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
Gorodensky A; Kohler JC
J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
[TBL] [Abstract][Full Text] [Related]
2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
Eccleston-Turner M; Upton H
Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
[TBL] [Abstract][Full Text] [Related]
3. The Race for Global Equitable Access to COVID-19 Vaccines.
Md Khairi LNH; Fahrni ML; Lazzarino AI
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
[TBL] [Abstract][Full Text] [Related]
4. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
Borges LC; Zeferino de Menezes H; Crosbie E
Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
[TBL] [Abstract][Full Text] [Related]
5. Risky business: COVAX and the financialization of global vaccine equity.
Stein F
Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
[TBL] [Abstract][Full Text] [Related]
6. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical Industry's Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers.
Sung M; Huang Y; Duan Y; Liu F; Jin Y; Zheng Z
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696293
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
[TBL] [Abstract][Full Text] [Related]
9. Vaccine inequity: a threat to Africa's recovery from COVID-19.
Wei CR; Kamande S; Lang'at GC
Trop Med Health; 2023 Dec; 51(1):69. PubMed ID: 38111032
[TBL] [Abstract][Full Text] [Related]
10. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
[TBL] [Abstract][Full Text] [Related]
11. COVAX and equitable access to COVID-19 vaccines.
Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
[TBL] [Abstract][Full Text] [Related]
12. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
So AD; Woo J
BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
[TBL] [Abstract][Full Text] [Related]
13. Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation.
Binagwaho A; Mathewos K; Davis S
Int J Health Policy Manag; 2022 Feb; 11(2):100-102. PubMed ID: 33949818
[TBL] [Abstract][Full Text] [Related]
14. COVAX, vaccine donations and the politics of global vaccine inequity.
de Bengy Puyvallée A; Storeng KT
Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
[TBL] [Abstract][Full Text] [Related]
15. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally.
ShamaeiZadeh PA; Jaimes CV; Knoll MD; Espié E; Chandler RE
Vaccine X; 2024 Jun; 18():100485. PubMed ID: 38655548
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
17. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
[TBL] [Abstract][Full Text] [Related]
18. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
[No Abstract] [Full Text] [Related]
19. Sustainable vaccine manufacturing in low- and middle-Income countries.
Hayman B; Kumar Suri R; Downham M
Vaccine; 2022 Nov; 40(50):7288-7304. PubMed ID: 36334966
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
